Back to results
US 11,633,377 B2Granted
Treatment of circadian rhythm disorders
AssigneeVanda Pharmaceuticals Inc.
InventorsMarlene Michelle Dressman, Louis William Licamele, Mihael H. Polymeropoulos
Life of this patent
Estimating the term…
Abstract
Embodiments of the invention relate to the use of a melatonin agonist in the treatment of free running circadian rhythms in patients, including light perception impaired patients, e.g., blind patients, and to methods of measuring circadian rhythm.
Claims11
In a method of administering tasimelteon to an individual, the improvement comprising:
- selecting for such administration an individual having a cortisol circadian rhythm that is not entrained to the individual's day/night cycle.
Dependencies are inferred from the claim text.